Mill Creek Life Sciences, LLC - Life Science & Health IT Division Semifinalist
Wednesday, June 27, 2018
Meet Mill Creek Life Sciences, LLC - one of the 10 Semifinalists in MN Cup’s Life Science & Health IT Division! Discover the other Minnesota Cup Semifinalists by browsing our blog and site.
[[{"fid":"130641","view_mode":"default","fields":{"format":"default","alignment":"","field_oc_caption[und][0][value]":"","field_file_image_alt_text[und][0][value]":"logo","field_file_image_title_text[und][0][value]":false,"field_body[und][0][value]":"","external_url":""},"link_text":null,"type":"media","field_deltas":{"1":{"format":"default","alignment":"","field_oc_caption[und][0][value]":"","field_file_image_alt_text[und][0][value]":"logo","field_file_image_title_text[und][0][value]":false,"field_body[und][0][value]":"","external_url":""}},"attributes":{"alt":"logo","style":"height: 197px; width: 350px;","class":"media-element file-default","data-delta":"1"}}]]
Mill Creek Life Sciences is a startup out of the Mayo Clinic’s Human Cell Therapy Lab and was the first company to bring human platelet lysate to the market for use in mesenchymal stromal cell (MSC) culture. Mill Creek’s original product, PLTMax®, has been used in used in nearly 50 Phase I, II, and III trials worldwide since 2010. In 2017, Mill Creek launched PLTGold®, a revolutionary new human platelet lysate that has no animal derived components, but all of the growth factors and potency of PLTMax®. In addition, Mill Creek has licensed technology for a new dendritic cell therapy to treat the brain cancer Glioblastoma. This builds on Mill Creek’s platform with the ability to prepare a patient’s immune system using in vitro, off the shelf technology. Mill Creek is ready to grow into a full therapeutic company in the cell therapy space. Check out their social media below!